An experimental xenograft mouse model of diffuse pontine glioma designed for therapeutic testing
about
DIPG in Children - What Can We Learn from the Past?Pre-Clinical Models of Diffuse Intrinsic Pontine GliomaPD-0332991, a CDK4/6 inhibitor, significantly prolongs survival in a genetically engineered mouse model of brainstem gliomaRecent advances of highly selective CDK4/6 inhibitors in breast cancerA Novel Technique for Generating and Observing Chemiluminescence in a Biological SettingA Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma (DIPG).Pharmacologic inhibition of histone demethylation as a therapy for pediatric brainstem gliomaEffect of time from diagnosis to start of radiotherapy on children with diffuse intrinsic pontine gliomaThe emerging role of NG2 in pediatric diffuse intrinsic pontine glioma.Development of a DIPG Orthotopic Model in Mice Using an Implantable Guide-Screw System.Paediatric and adult malignant glioma: close relatives or distant cousins?Pediatric diffuse intrinsic pontine glioma: can optimism replace pessimism?Diffuse intrinsic pontine glioma: time for therapeutic optimism.Patient-derived Tumor Models for Diffuse Intrinsic Pontine Gliomas.Clinically applicable human adipose tissue-derived mesenchymal stem cells delivering therapeutic genes to brainstem gliomas.New therapeutic approaches for brainstem tumors: a comparison of delivery routes using nanoliposomal irinotecan in an animal model.Patient-derived DIPG cells preserve stem-like characteristics and generate orthotopic tumors.In Vivo (19)F-Magnetic Resonance Imaging of Adoptively Transferred NK Cells.Combined use of CDK4/6 and mTOR inhibitors induce synergistic growth arrest of diffuse intrinsic pontine glioma cells via mutual downregulation of mTORC1 activity
P2860
Q26777843-DC628239-AE3B-4FBE-A40F-9F5B03FB84B5Q26799976-3495C4A3-7492-4FD7-9746-92FDA71F5BB8Q28533981-0D61964A-B466-4026-B4A6-70BC7E023EA7Q33602076-44B7A646-AB13-4C28-B5AB-3DA27404ACAEQ33610471-559F08B6-BA82-4BB6-8A72-5E59FBA256EEQ33615351-751F6734-7BBE-4B44-B559-097267E1774FQ34641903-B58A3BA5-A3DB-43DE-A3A4-673F30BC1B9AQ35230772-825BB85B-FE8B-493A-8617-6ABB07750C6DQ35828522-9B34C3FC-D3B9-44A9-B3E9-D6874322134EQ36255670-442355BA-A2E2-4604-8C4D-C45D2211EF7EQ38013990-8681DA0D-4CF9-4C66-BA68-D41B9D239433Q38233425-E2F21E68-B471-474B-98A4-FAD9B8507128Q38264309-726BE812-C743-4723-B567-AF45298E2954Q38841339-E6B34CE3-3CF2-42D6-8EB6-6228B438A835Q38869957-B523A304-E0DC-4913-8C9A-9C3B02E5DB88Q45945184-1876E09F-FB8B-4EA3-B8F5-375643E8B3D5Q47158930-16015C86-861A-40E4-998A-ADF678CFAE12Q48737848-7DAC5A19-5D3C-4A58-9DA7-98D74CAF2F8AQ58746764-F064ADB7-DD2E-445F-8645-DED56C4C5AE2
P2860
An experimental xenograft mouse model of diffuse pontine glioma designed for therapeutic testing
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 January 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
An experimental xenograft mous ...... signed for therapeutic testing
@en
An experimental xenograft mous ...... igned for therapeutic testing.
@nl
type
label
An experimental xenograft mous ...... signed for therapeutic testing
@en
An experimental xenograft mous ...... igned for therapeutic testing.
@nl
prefLabel
An experimental xenograft mous ...... signed for therapeutic testing
@en
An experimental xenograft mous ...... igned for therapeutic testing.
@nl
P2093
P2860
P1476
An experimental xenograft mous ...... signed for therapeutic testing
@en
P2093
Anu Banerjee
C David James
Michael Prados
Nalin Gupta
Rintaro Hashizume
Tomoko Ozawa
Yasuyuki Aoki
P2860
P2888
P356
10.1007/S11060-011-0796-X
P577
2012-01-10T00:00:00Z